Published 1 day ago • loading... • Updated 1 day ago

Palisades Therapeutics Granted Breakthrough Patent for Novel Addiction Treatment

Summary by kalkinemedia.com

Next-Generation Compounds Show Promise CLIFFSIDE PARK, NJ, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- Pop Test Oncology LLC dba Palisades Therapeutics proudly announces that the United States Patent and Trademark Office (USPTO) has granted a groundbreaking patent for an innovative pharmaceutical composition and treatment method aimed at combating addiction and related disorders. This new approach offers hope for millions struggling with …

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

ROI-NJ

Palisades Therapeutics awarded patent for breakthrough addiction treatment

Pop Test Oncology LLC, doing business as Palisades Therapeutics, has been granted a U.S. patent for a new pharmaceutical composition and personalized treatment method targeting addiction and related disorders. The patented compounds—PT155, PT156, PT157, and PT158—are next-generation analogs of PT150, a Phase 2 clinical-stage drug shown to reduce addiction behaviors and withdrawal symptoms in preclinical studies. Early research has demonstrated p…

1 day ago

Read Full Article